For instance, peptides with significantly negative ΔGbinding values, such as Apelin with VEGFR2 (−199.17 kcal/mol) and APJ (−171.62 kcal/mol), suggest high binding stability, potentially enhancing their effectiveness in CAD treatment. The gene discussed is APLNR; the disease is coronary artery disorder.